Further studies will be required to explore the potential link between SPRY2 and these genes in the context of obesity and T2DM, and in particular, the potential role of SPRY2 in the pathogenesis of liver diseases, such as NAFLD. The gene discussed is SPRY2; the disease is metabolic dysfunction-associated steatotic liver disease.